Inventiva S.A. (LON:0RNK)
5.24
+0.10 (1.93%)
Feb 12, 2026, 4:24 PM GMT
Inventiva Revenue
Inventiva had revenue of 2.81M EUR in the half year ending June 30, 2025, with 105.19% growth. This brings the company's revenue in the last twelve months to 13.61M, down -12.84% year-over-year. In the year 2024, Inventiva had annual revenue of 14.72M, down -36.43%.
Revenue (ttm)
13.61M EUR
Revenue Growth
-12.84%
P/S Ratio
60.06
Revenue / Employee
162.04K EUR
Employees
84
Market Cap
873.67M GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 14.72M | -8.44M | -36.43% |
| Dec 31, 2023 | 23.16M | 4.35M | 23.12% |
| Dec 31, 2022 | 18.81M | 10.31M | 121.32% |
| Dec 31, 2021 | 8.50M | 3.24M | 61.52% |
| Dec 31, 2020 | 5.26M | -6.03M | -53.39% |
| Dec 31, 2019 | 11.29M | 3.91M | 53.02% |
| Dec 31, 2018 | 7.38M | -2.58M | -25.90% |
| Dec 31, 2017 | 9.96M | 512.36K | 5.42% |
| Dec 31, 2016 | 9.45M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.24B |
| GSK plc | 32.67B |
| Haleon | 11.02B |
| Smith & Nephew | 4.33B |
| Spire Healthcare Group | 1.55B |
| CVS Group | 673.20M |
| Advanced Medical Solutions Group | 220.30M |
| Oxford Nanopore Technologies | 204.69M |
Inventiva News
- 8 days ago - Inventiva to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026 - GlobeNewsWire
- 15 days ago - Biotech Inventiva's 50% surge shows investor optimism over liver disease drug - Reuters
- 15 days ago - Inventiva (IVA) Receives Overweight Rating as Barclays Initiates Coverage | IVA Stock News - GuruFocus
- 4 weeks ago - Inventiva SA at JPMorgan Healthcare Conference Transcript - GuruFocus
- 4 weeks ago - Inventiva S.A. (IVA) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow - Seeking Alpha
- 4 weeks ago - Inventiva S.A. (IVA) Presents at 44th Annual J.P. - Seeking Alpha
- 4 weeks ago - Inventiva (IVA) Initiates Coverage with "Outperform" Rating by Leerink Partners | IVA ... - GuruFocus
- 5 weeks ago - Wall Street Analysts Predict a 200.59% Upside in Inventiva (IVA): Here's What You Should Know - Nasdaq